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16. Mouse cerebellar cultures were prepared and main-
tained by the method of K. Schilling, M. Dickinson,
J. Connor, and J. Morgan (Neuron, in press) as
previously described (6). Cultures used for record-
ing had been maintained in vitro for 12 to 24 days.
PNs were chosen for recording by distinct morpho-
logical criteria (large round soma, prominent den-
dritic arbor) as verified by staining with the PN-
specific immunochemical markers PEP-19 [L.
Sangameswaran, J. Hempstead, J. Morgan, Proc.
Nati. Acad. Sci. U.S.A. 86, 5651 (1989)] and
calbindin-D28K [M. Thomasset et al., Dev. Pharma-
col. Ther. 7, 6 (1984)]. Nystatin patch electrodes
[R. Horn and A. Marty, J. Gen. Physiol. 92, 145
(1988)] were attached to PN somata and were used
to apply a holding potential of -80 mV. Ionto-
phoresis electrodes (tip diameter, <0.5 Alm) were
filled with excitatory amino acid receptor agonists
and were positioned -20 glm away from a large-
caliber dendrite 10 to 20 gm from the soma. Pulses
of agonists (30 to 100 ms duration) were applied at
a frequency of 0.05 Hz. After acquisition of 15 min
of baseline responses, we induced LTD by pairing
six successive glutamate test pulses with six 4-s
depolarization steps to -10 mV, timed so that the
depolarization onset preceded the glutamate pulse
by 500 ms. This treatment reliably induced a stable
depression of the glutamate-mediated inward cur-
rent (typically 50 to 65% of its baseline value) that
was independent of alterations in input resistance or
resting potential (6; D. J. Linden and J. A. Connor,
in preparation). Cells were bathed in a solution (adjust-
ed to pH 7.35 with NaOH) that contained NaCI (150
mM), KCI (5 mM), CaCI2 (2 mM), MgC2 (0.8 mM),
Hepes (10 mM), glucose (10 mM), tetrodotoxmn
(0.005 mM), and picrotoxin (0.1 mM). Tetrodotoxin
and picrotoxin were added to the external saline to
improve the resolution of the voltage clamp and to
block spontaneous synaptic potentials, but the addition
ofthese compounds was not required for the induction
ofLTD. For recordings ofvoltage-garedCa2+ currents
(as in Fig. 1C), 10 mM TEA-Cl was added. The
internal saline (adjusted to pH 7.35 with KOH) con-
sisted of K2S04 (95 mM), KCI (15 mM), MgCI2 (8
mM), and Hepes (10 mM). For Ca2+ current record-
ing, Cs2SO4 and CsCl were substituted for K2S04 and
KCI, respectively, in an equimolar fashion. Patch elec-
trodes were pulled fromN5lA glass (Garner Glass Co.,
Claremont, CA) and polished on a microforge to yield
a resistance of 1 to 3 megohms when measured with
normal internal and external salines. Nystatin (250
ig/ml) was added to the electrode filling saline. This
concentration gave access resistance to the cell that was
typically <10 megohms. Only cells with stable resting
potentials of > -45 mV were used. Membrane cur-
rents induced by application of excitatory amino acids
were stored on a chart recorder that imposed a 0- to
30-Hz bandpass. Membrane currents in response to
voltage steps were filtered at 3 kHz, digitized with a
12-bit analog-to-digital converter operating at a sam-
pling frequency of20 kHz, and stored on the hard disk
of an INDEC-LSI-11/23 computer. Leakage current
was determined from 10-mV hyperpolarizing pulses
and was digitally subtracted from records of voltage-
gated currents. Experiments were conducted at 220 to
240C. Imaging of intracellular free Ca2+ with the
indicator fura-2/AM was performed as described [J. A.
Connor, Proc. Nad. Acad. Sci. U.SA. 83, 6179
(1986)].
17. Excitory amino acid receptor agonists were delivered
by iontophoresis and were prepared in 10 mM
Hepes as follows: 10 mM glutamate (pH 7.1); 10
mM quisqualate (pH 7.2); 10 mM AMPA (pH
7.1); 100mM NMDA (pH 7.3). These compounds
were delivered through polished patch pipettes (re-
sistance, 4 to 6 megohms when filled with normal
internal saline) with negative current pulses. Braking
currents were applied to prevent drug leakage.
18. E. Kobayashi, H. Nakano, M. Morimoto, T.
Tamaoki, Biochem. Biophys. Res. Commun. 159, 548
(1989). The following IC50 values are reported for
calphostin C inhibition of purified protein kinases,
with a histone protein substrate: PKC, 0.05 paM;
adenosine 3',5'-monophosphate (cAMP)-depen-
dent kinase, >50.00 jaM; guanosine 3',5'-mono-
phosphate (cGMP)-dependent kinase, >25.00 SLM;
myosin light-chain kinase >5.00 p.M.
19. P. D. Davis et aL ,FEBS L-t. 259,61 (1989). RO-31-
8220 is referred to as compound 3 in this reference. The
following inhibition concentration (ICSO) values are
reported for RO-31-8220 inhibition ofpurified protein
kinases as measured in the presence ofATP (10 pLM),
with a histone protein substrate: PKC, 0.01 pM;
cAMP-dependent kinase, 1.5 gM; Ca2+/calmodulin
dependent kinase, 17 FM.
20. C. House and B. E. Kemp, Science 238, 1726
(1987); R. Malinow, H. Schuiman, R. W. Tsien,
ibid. 245, 862 (1989).
21. 0. P. Hamill, A. Marty, E. Neher, B. Sakmann, F. J.
Sigworth, Pfluegeirs Arch. 391, 85 (1981). Conven-
tional whole-cell recordings (Fig. IC) were made with
the same configuration as describedfor perforated patch
recording, except that a different internal saline was
used and nystatin was omitted from the recording
electrode. This internal saline contained KCl (140
mM), Hepes (10 mM), andMg-ATP (2 mM), adjusted
to pH 7.35 with KOH. Chelators of Ca2+ were
omitted to avoid blocking induction of LTD. When
K4BAPTA (20 mM) was added to block LTD, 50 KCl
was removed to compensate for the change in osmolar-
ity.
22. D. J. Linden and J. A. Connor, unpublished obser-
vations.
23. Studies with exogenous agonists have shown a
developmental decrease in the response of PNs to
NMDA, resulting in a complete lack of sensitivity to
this compound in the adult [J. L. Dupont, G. Gardette,
F. Crepel, Dev. Brain Res. 34, 59 (1987); G. Garth-
waite, B. Yamani, J. Garthwaite, ibid. 36, 288 (1987);
E. Audinat, T. Knopfel, B. H. Gahwiler, J. Physiol.
(London) 430,297 (1990)]. Ourcultures ofembryonic
PNs showedNMDA responses typical ofthose seen in
other neuronal types: that is, they were attenuated by
DL-2-amino-5-phosphonopentanoic acid (APS) and
exhibited a Mg2` and voltage-dependent block. When
the membrane potential was damped to -80 mV, the
NMDA response became very small (<10% of the
glutamate current was blocked by 20 p.M APS at this
potential). To produce NMDA currents of easily mea-
surable amplitude (as in Fig. 3), membrane potential
was clamped to -65 mV, and NMDA pulses were
typically applied for durations two to three times thatof
AMPA.
24. M. Castagna et al., J. Biol. Chem. 257, 7847
(1982).
25. Y. Nishizuka, Science 233, 305 (1986).
26. R. Malinow, D. V. Madison, R. W. Tsien, Nature
335, 820 (1988); T. H. Brown, P. F. Chapman, E.
W. Kairiss, C. L. Keenan, Science 242, 724 (1988).
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Targeting of the Master Receptor MOML9 to
Mitochondria
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The targeting of proteins to mitochondria involves the recognition of the precursor
proteins by receptors on the mitochondrial surface followed by insertion of the
precursors into the outer membrane at the general insertion site GIP. Most mitochon-
drial proteins analyzed so far use a mitochondrial outer membrane protein of 19
kilodaltons (MOM19) as an import receptor. The gene encoding MOM19 has now
been isolated. The deduced amino acid sequence predicts that MOM19 is anchored in
the outer membrane by an NH2-terminal hydrophobic sequence, while the rest of the
protein forms a hydrophilic domain exposed to the cytosol. MOM19 was targeted to
the mitochondria via a pathway that is independent of protease-accessible surface
receptors and controlled by direct assembly of the MOML9 precursor with GIP.
T HE BIOGENESIS OF MITOCHONDRIA
involves the translocation of cytosol-
ically synthesized precursor proteins
into or across the organellar membranes (1,
2). In Neurospora crassa, two mitochondrial
outer membrane proteins (MOMs) were
identified as import receptors for precursor
proteins. The 19-kD protein MOM19 func-
tions as a receptor for most precursors ana-
lyzed, including all precursors that carry an
NH2-terminal signal sequence (3-5), and is
referred to as the master receptor. The 72-
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kD protein MOM72 is a receptor for the
precursor of the adenosine diphosphate-
adenosine triphosphate (ADP-ATP) carrier,
which contains internal targeting signals (4,
6). Precursor proteins interact with these
receptors and are inserted into the outer
membrane at a common site, termed the
general insertion site (general insertion pro-
tein = GIP) (7, 8). The 38-kD protein
MOM38 forms part of the GIP and is
assembled with MOM19 and MOM72 in
the mitochondrial receptor complex (9). To
determine the mechanism by which the mas-
ter receptor is targeted to mitochondria, we
investigated the biogenesis ofMOMl9.
A full-length cDNA clone that encodes
MOM19 from N. crassa was isolated (10)
and used to obtain the complete MOMl9
gene (11). The nucleotide sequences ofboth
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the cDNA and the gene (containing three
introns) were determined. The predicted
protein, with 181 amino acids (Fig. lA) and
a molecular mass of 20,206, was in good
agreement with the apparent molecular size
of 19 kD (3). The 3'-untranslated region of
the cDNA was 642 nucleotides (nt) and
contained a fragmentary poly(A) stretch. To
confirm the identity of the MOM19 cDNA,
we purified MOM19 from isolated mito-
chondria (3) and determined amino acid
sequences of four peptides derived. All of
the peptide sequences matched the deduced
amino acid sequence, with the exception of
the NH2-terminal methionine, which was
not found in the mature protein (Fig. 1
caption).
MOM19 contains a hydrophobic se-
quence of 26 amino acids at the NH2 ter-
minus (Fig. lA) that may anchor the protein
in the outer membrane. The rest of the
protein is hydrophilic and probably forms a
cytosolic domain, in agreement with the
protease accessibility of MOM19 in intact
mitochondria (3). In addition, MOM19
contains clusters of arginine residues (Fig.
LA), and amino acid residues 42 to 59 are
predicted to form an amphipathic a helix
(12). Amino acid residues 92 to 174 of
A
,,,+-++ 4 44 +-~
MOMl9 are 42% similar to residues 712 to
797 of a-actinin from Ditayostelium discoi-
deum (13), suggesting that MOML9 could
function in the interaction of mitochondria
with the cytoskeleton. Residues 107 to 160
show a similarity of45% to residues 419 to
469 of the plasma membrane HW-depen-
dent ATPase (H4-ATPase) of Schizosaccha-
romyces pombe (14).
The MOM19 cDNA was expressed in
Escherichia coli, and inclusion bodies con-
taining MOM19 were purified, separated on
SDS-polyacrylamide gels, and transferred to
nitrocellulose. The protein band corre-
sponding to MOM19 was used to generate
polyclonal antibodies in rabbits. These anti-
bodies specifically recognized MOML9 in
isolated mitochondria by immunodecora-
tion and immunoprecipitation as shown for
antibodies prepared against purified
MOML9 (3). To determine whether anti-
bodies prepared against cloned MOML9
showed the same specific inhibitory effect on
mitochondrial protein import as antibodies
prepared against MOM19 purified from
outer membranes (3), immunoglobulins G
(IgGs) and Fab fragments were prepared.
Fab fragments were prebound to isolated N.
crassa mitochondria, and the in vitro import
B
~RFR m F, P-t4DPE0AETYTTAAVAADLPRRYRSARQAQE LSQAQA
QMDEAIEGFPTTSDEAYFLEQVVQ PTDAIDAASIAYKAIXVYPTPGDISIYDKTVA
+_E_
IPIIDILdYPSLKIGTNXTGGVDVAELMEMSAPGVGL
123 4 5 6
Fig. 1. Primary structure of N. crassa MOM19. (A) Amino acid,-tx
sequence of MOM19. A full-length cDNA coding for N. crassa 50
MOM19 was isolated from a cDNA library in Xgtll (10) by
antibody screening (23), and the cDNA was used to obtain the gene
from a genomic library in pBR322 (11). The nucleotide sequence 0
data are available from GenBank under accession number M80528. 100
Abbreviations for the amino acid residues are the following: A, Ala; 2
C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, C
Leu; M, Met; N, Asn; P, Pro; Q, Gin; R, Arg; S, Ser; T, Thr; V, c 50
Val; W, Trp; and Y, Tyr. The hydrophobic segment ofMOM19 is
underlined. Sequence analysis of the NH2 terminus and of three
tryptic fragments of purified MOM19 (3) was performed as de- 0
scribed (24, 25). The sequences were identical to the residues 2 E~ 100.through 27, 54 through 58, 107 through 116, and 171 through
179 of the deduced sequence. (B) Antibodies prepared against the
cloned MOM19 inhibit the import of precursor proteins into 9 50
mitochondria. The cDNA of MOM19 cloned into pUHE25 was
expressed in the E. coli strain BMH71-18. Inclusion bodies con-
taining MOM19 were isolated, and antibodies (IgGs and Fab -
fragments) were prepared (3, 26). Fab fragments [15 pug, except
lanes 1 and 7 (no Fab fragments) and lane 2 (5 ug)] were prebound >,
to isolated N. crassa mitochondria (10 ug of protein). Rabbit v m
reticulocyte lysate (5 iAl) containing the 35S-labeled precursor .
proteins of F1-ATPase subunit P (FIy), cytochrome cl (Cyt. cl),
porin, or ADP-ATP carrier (AACX respectively, was added to the
energized mitochondria (3, 6, 26). After incubation for 7 min at
250C, the mitochondria were treated with proteinase K (26), and reisolated, and the proteins were
analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), fluorography, and laser densitom-
etry. The amount of protein imported into mitochondria not carrying Fab fragments (lane 1, control)
was set to 100%. The values are averages of five determinations with SEMs less than 5%. Lanes 2 and
3, anti-MOM19c, Fab fragments to MOM19 expressed in E. coli; lane 4, anti-MOM19, Fab fragments
to MOM19 obtained from purified MOMs (3); lane 5, anti-Porin, Fab fragments to porin; lane 6,
preimmune Fab fragments; "bypass" (lane 7) denotes import into mitochondria pretreated with trypsin
(20 gg/ml) (3, 6, 21, 26); mF1P denotes mature F1P.
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100
of various precursor proteins was analyzed
(Fig. lB). The import of F,-ATPase subunit
13, cytochrome cl, and porin was strongly
inhibited, whereas the import of the ADP-
ATP carrier [which uses both receptors, but
predominantly MOM72 (4, 6)] was only
partly inhibited. Thus, the inhibitory effect
ofthe antibodies toMOML9 is independent
of the source of the MOM19 used for
immunization, indicating that the inhibitory
effect of the original antibodies to MOML9
was not caused by another MOM protein
that might have been present in the prepa-
ration used for generation of the original
antibodies (3).
The precursor ofMOM72 uses MOM19
as a receptor (6). Thus, we sought to deter-
mine whether the master receptor MOM19
needed a receptor for import. The MOMl9
precursor was synthesized in rabbit reticulo-
cyte lysate in the presence of [35S]methion-
ine, and lysate containing MOM19 precur-
sor was incubated with isolated N. crassa
mitochondria. The precursor efficiently as-
sociated with the mitochondria (about 80%
of the precursor added), whereas no associ-
ation was found with other membranes such
as microsomes (Fig. 2A). To analyze for
correct import of MOML9 into mitochon-
dria in vitro, we made use of a property of
MOMl9 imported in vivo. A treatment of
mitochondria with elastase produces a char-
acteristic proteolytic pattern ofMOML9; in
particular, a 17-kD fragment (termed
MOMl9') is formed (3). The identical pat-
tern was generated from MOM19 imported
in vitro (Fig. 2B). The nonimported precur-
sor in the reticulocyte lysate did not yield
this pattern but was further degraded (Fig.
2B). Using the formation ofMOM19' as a
specific assay for the import ofMOMl9, we
found that a pretreatment of mitochondria
with protease did not inhibit the import of
MOM19 (Fig. 2C). We performed the assay
for import of MOM19 in the kinetically
linear range; pretreatment with protease
completely degraded the preexisting surface
receptors MOM19 and MOM72 and inhib-
ited the binding and import of numerous
other precursor proteins (3, 4, 6, 8). Thus,
the import ofMOMl9 does not require any
of the known receptors or other protease-
accessible surface receptors.
The finding of a means of import of
MOM19 independent of a surface receptor
raises the question of how a mitochondrion
controls the specificity of import of its mas-
ter receptor. In the mitochondrial receptor
complex, MOM19 is particularly tightly as-
sociated with MOM38 (9). The specific
interaction with M0M38 might thus be
responsible for the specificity of MOM19
import. The MOM38 from N. crassa is a
tightly folded protein, and antibodies recog-
SCIENCE, VOL. 254
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Fig. 2. Lack of a requirement of a surface receptor for the import of
MOM19 into N. crassa mitochondria. (A) The precursor of MOM19
efficiently binds to isolated mitochondria but not to microsomes.
MOM19 (cDNA cloned into pGEM4) was synthesized in rabbit retic-
ulocyte lysate in the presence of [35S]methionine (26). Lysate (2 pi) was
incubated with isolated mitochondria (10 pg of protein) or microsomes
(10 [ig of protein) for 15 min at 25'C in a final volume of 75 pl
(including 100 mM of KCl) as described (26). The membranes were
reisolated by centrifugation and washed in 100 mM sucrose, 1 mM
EDTA, 10 mM MOPS, pH 7.2, 100 mM KC1, and the proteins were
analyzed as described in the caption of Fig. 1B. The values are averages
of four determinations with SEMs less than 7%. The precursor of
MOM19 showed the same apparent size as the mature protein, and its
import into mitochondria did not require a membrane potential across
the inner membrane, as is generally found with outer membrane proteins
(2). F, free; MB, membrane bound. (B) Formation of a characteristic
17-kD fragment (MOM19') of imported MOM19. MOM19 synthe-
sized in vitro was imported into isolated mitochondria for 7 min at 25'C.
After treatment with elastase, the mitochondria were reisolated, washed,
and analyzed by SDS-PAGE and fluorography. From parallel samples,
mitochondria were transferred to nitrocellulose and treated with anti-
bodies against MOM19 (3) (import in vivo). Rabbit reticulocyte lysate
containing the precursor ofMOM19 was treated with elastase under the
conditions used for the treatment of mitochondria (3) (precursor). (C)
Import of MOM19 into mitochondria does not require a surface
receptor. Mitochondria were pretreated with trypsin (26) and incubated
with reticulocyte lysate containing the precursors of MOM19(@), F10
(A), or AAC (N) for 5 min at 15°C, followed by a treatment with elastase.
The amount of protein imported into mitochondria not treated with
trypsin was set to 100% (control). The values are averages of five
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determinations with SEMs less than 5%. The rate of import linearily
depended on the time of incubation and the amount of mitochondria.
Preincubation of the mitochondria with antibodies to MOM19 (3) also
did not inhibit the import of newly synthesized MOM19.
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Fig. 3. Assembly of N. crassa MOM19 and M0M72 into the t5
receptor complex of S. cerevisiae mitochondria. (A) Assembly into E
yeast mitochondria. Rabbit reticulocyte lysates (7.5 pI) contain- -
ing the 35S-labeled precursors of N. crassa MOM19 (lanes 1 o so 100 150
through 3 and 7 through 15) and MOM72 (lanes 4 through 15) IgG (jig)
were incubated with isolated yeast mitochondria (25 pg of
protein) for 5 min at 25°C (26) (lanes 10 through 12 received mitochondria lysed with buffer
containing 0.5% digitonin). The mitochondria of lanes 1 through 9 and 13 through 15 were
reisolated, washed in 100 mM sucrose, 1 mM EDTA, 10 mM MOPS, pH 7.2, and solubilized in
buffer containing 0.5% digitonin (lanes 1 through 9) (9) or in SDS-containing buffer (lanes 13
through 15) (3, 9). Immunoprecipitations were performed with antibodies directed to N. crassa
MOM19 (lanes 1, 7, 10, and 13), MOM72 (lanes 4, 7, 10, and 13), yeast MOM38 (=ISP42) (lanes
2, 5, 8, 11, and 14), and preimmune antibodies (lanes 3, 6, 9, 12, and 15) (9). The specificity of the
antibodies to yeast MOM38 was shown by immunoprecipitation of SDS-lysed yeast mitochondria
labeled with 35S (lane 16). (B) Assembly ofMOM19 does not require a known surface receptor.
Yeast mitochondria were pretreated with trypsin (26). N. crassa MOM 19 (-) and MOM72 (A) were
imported, and coimmunoprecipitations with anti-MOM38-ISP42 antibodies were performed as
described above. The amount of protein that coprecipitated with mitochondria that were not treated
with trypsin was set to 100% (control) (similar results were obtained when the import was
performed at lower temperature, 15°C or 0°C). The values are averages of five determinations with
SEMs less than 6%. (C) MOM38 (=1SP42) is needed for import of MOM19. Isolated yeast
mitochondria (10 jig) were preincubated with IgGs to MOM38 (closed symbols) or preimmune
IgGs (open symbols) (3, 6, 26). Precursors ofMOM19 (0) and AAC (E) were imported, and the
mitochondria were treated with elastase as described above. For import ofMOM19, the mitochon-
dria were pretreated with trypsin (5 gg/ml). The amount of protein imported into mitochondria not
carrying IgGs was set to 100% (control). The values are averages of at least three determinations
with SEMs less than 8%.
nizing the native protein are not available
(9), rendering a direct assay with N. crassa
mitochondria impossible. The Saccharomyces
cerevisiae equivalent of MOM38, also
termed ISP42 (15, 16), is more easily acces-
sible to antibodies, probably as a result of an
extra sequence of about 20 amino acid resi-
dues at the NH2 terminus (9). We prepared
monospecific antibodies to yeast MOM38
(Fig. 3A) that efficiently recognized the
native protein (anti-MOM38). MOM19
from N. crassa was imported into yeast
mitochondria and assembled into the yeast
receptor complex, as shown by the coprecip-
itation ofMOM19 with anti-MOM38 (Fig.
3A, lanes 2 and 8). Assembly with MOM38
did not occur when reticulocyte lysate con-
taining the radioactively labeled precursor
was incubated with lysed mitochondria
(Fig. 3A, lane 11), indicating that import of
the MOM19 precursor into intact mito-
chondria is a prerequisite for the assembly of
MOM19 with MOM38. MOM72 from N.
crassa also correctly assembled into the re-
ceptor complex of yeast mitochondria (Fig.
3A, lanes 5 and 8), showing a high conserva-
tion of the mitochondrial protein import
machinery between N. crassa and S. cerevisiae.
Yeast mitochondria were pretreated with
trypsin so that surface receptors, but not
MOM38, were degraded, leading to inhibi-
tion of import of various precursor proteins
(Fig. 3B) (4, 17). Import and assembly of
MOM19, however, were still possible. To
further analyze whether MOM38 is needed
13 DECEMBER 1991
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for the import of MOM19, we sought to
determine whether antibodies to yeast
MOM38 (anti-MOM38) affected the im-
port and assembly ofMOM19. Prebinding
of anti-MOM38 to mitochondria inhibited
the import ofMOM19 (Fig. 3C), confirm-
ing thatMOM38 is involved in this process.
The studies conducted thus far indicate
that components of the mitochondrial pro-
tein import machinery participate in their
own biogenesis pathway. These components
include mitochondrial hsp70 (18), the mito-
chondrial processing peptidase (10, 19), and
hsp60 (20). MOMl9 is a component of the
import machinery that does not need its
own function or that of an analogous com-
ponent (receptor) for import, although the
involvement ofan additional unknown com-
ponent cannot be fully excluded. We suggest
that the receptor-independent interaction
with MOM38 represents an evolutionary
remnant form of mitochondrial protein im-
port, allowing specific import without a
need for surface receptors. This finding
sheds new light on a previous unexpected
result, namely, the import of a number of
authentic mitochondrial precursor proteins
into mitochondria that lack surface receptors
(21). This so-called bypass import occurred
with a low efficiency in most but not all
cases; its mechanism and specificity re-
mained unclear. The import of MOMl9
shows that the interaction with MOM38
allows a specific and highly efficient import
in the absence of surface receptors, raising a
similar possibility for other precursor pro-
teins [this pathway has to be distinguished
from the unique import pathway of the
precursor of cytochrome c that possesses an
endogenous- membrane insertion activity
and does not use any of the known MOM
proteins; the import of this precursor is
controlled by the specific interaction with
the cytochrome c heme lyase in the inter-
membrane space (2, 3, 11)]. The ability of
MOM38 to target and insert mitochondrial
precursor proteins could be harmful to the
cell; mistargeting of MOM38 to another
cellular compartment might lead to import
ofMOMl9, which would allow the efficient
targeting ofmany mitochondrial proteins to
another compartment. This possibility can
be excluded, because the biogenesis of
MOM38 strictly depends on the presence of
a mitochondrial surface receptor (22).
Therefore, the early components of the
mitochondrial protein import machinery
cannot effect their own import, so an effiec-
tive control system exists for the specific
assembly of the protein import apparatus
only at the appropriate location.
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